MedPath

Dermatophagoides farinae

Generic Name
Dermatophagoides farinae
Brand Names
Acarizax, Odactra
Drug Type
Biotech
Unique Ingredient Identifier
PR9U2YPF3Q

Overview

Dermatophagoides farinae extracts are sterile solutions used for intradermal testing or subcutaneous immunotherapy. This combination is approved for as a year-round, once-a-day tablet that's dissolved under the tongue as a treatment for dust mite allergies.

Background

Dermatophagoides farinae extracts are sterile solutions used for intradermal testing or subcutaneous immunotherapy. This combination is approved for as a year-round, once-a-day tablet that's dissolved under the tongue as a treatment for dust mite allergies.

Indication

Dermatophagoides farinae is indicated as immunotherapy for house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, confirmed by in vitro testing for IgE antibodies to Dermatophagoides farinae or Dermatophagoides pteronyssinus house dust mites, or skin testing to licensed house dust mite allergen extracts. It is approved for use in patients 12 through 65 years of age.

Associated Conditions

  • House Dust Mite Allergy

FDA Approved Products

Treatment Set TS344570
Manufacturer:Antigen Laboratories, Inc.
Route:SUBCUTANEOUS, INTRADERMAL
Strength:400 [AU] in 1 mL
Approved: 2011/02/03
NDC:49288-0837
Treatment Set TS341430
Manufacturer:Antigen Laboratories, Inc.
Route:SUBCUTANEOUS, INTRADERMAL
Strength:16 [AU] in 1 mL
Approved: 2011/06/08
NDC:49288-0814
Treatment Set TS335823
Manufacturer:Antigen Laboratories, Inc.
Route:SUBCUTANEOUS, INTRADERMAL
Strength:16 [AU] in 1 mL
Approved: 2010/05/06
NDC:49288-0782
Treatment Set TS345476
Manufacturer:Antigen Laboratories, Inc.
Route:SUBCUTANEOUS, INTRADERMAL
Strength:1000 [AU] in 1 mL
Approved: 2012/05/11
NDC:49288-0849
Treatment Set TS346157
Manufacturer:Antigen Laboratories, Inc.
Route:SUBCUTANEOUS, INTRADERMAL
Strength:1000 [AU] in 1 mL
Approved: 2012/05/11
NDC:49288-0854

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath